Abbott announced it has received European CE Mark approval for the Esprit below-the-knee (BTK) everolimus-eluting resorbable ...

A summary of clinical outcomes from the Vascular and Endovascular Access Society (SAVE)* patient registry in Brazil, ...

Patient throughput and management of GI bleeds, from initial presentation through definitive management. Gastrointestinal (GI ...

A Q&A addressing common questions around coding, payment models, and value-based care alignment for percutaneous transmural ...

Dr. Jabbour discusses the evolution of transradial access for neurointervention, his collaboration with Wills Eye Hospital on ...

Otsuka Medical Devices Co., Ltd. announced that the Paradise ultrasound renal denervation (uRDN) system has received manufacturi ...

Impact of the NCD on referrals and volumes of transfemoral carotid artery stenting, the multidisciplinary approach to evaluation and treatment, considering patient factors and patient preference, ...

The introduction of mechanical thrombectomy and PERTs has ushered in a new era of pulmonary embolism management, involving standardized, team-based, clinical decision-making pathways; expanded ...

After the 2018 Journal of the American Heart Association (JAHA) meta-analysis suggesting an early mortality signal in ...

Reflections on what is lost and gained when a well-designed trial produces unexpected results.

Michael Chen, MD Professor of Neurology, Neurosurgery & Radiology Rush University Medical Center Chicago, Illinois michael_chen@rush.edu ...

The evolution of EVAR follow-up protocols reflects a broader trend toward precision, patient-centered care. By integrating patient-specific risk factors, procedural details, and advanced imaging ...